title: Branded drug reformulation: the next brand vs. generic antitrust battleground.
authors: Gibbons P.C., Newark, NJ, USA.
authors: Guy V
authors: GV
authors: Amoresano
mesh_terms: D016363:Antitrust Laws; D003132:Commerce / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics; D004465:Economic Competition / Q000191:economics / Q000331:legislation & jurisprudence; D017850:Economics, Pharmaceutical; D006801:Humans; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic